HPV16-RG1VLP

N/A

Report date: 2025/09/30 20:00:06

Base Information

Drug NameHPV16-RG1VLP
Drug Alias NameRGVaxHPV vaccineVLP HPV vaccinehuman papilloma virus vaccineRG1-VLPs +[10] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPathoVax LLC
China Registration ClassN/A

Develop Information

Active CompaniesPathoVax LLCNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A